How are LRMR's technical signals calculated?

Scanance computes LRMR's technicals daily after market close from end-of-day OHLCV data. MA150 and MA200 are simple moving averages. RSI uses Wilder's 14-period smoothing. MACD uses 12/26/9 exponential moving averages. Volume ratio compares current volume to the 20-day average.

Scanance does not provide investment advice. The technical readouts on this page are pattern matches against deterministic indicator rules. They are not buy or sell recommendations. Always do your own research and consider consulting a licensed financial professional before making any trade.

LR

Larimar Therapeutics, Inc.

LRMRHealthcareNASDAQ

Biotechnology

PriceMA150MA200

Loading chart…

End-of-day data · ScananceOpen live chart on TradingView ↗

Indicator snapshot · Today

Premium

Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →

Scan Results

Daily timeframe

1 recent day hidden. Fresh signals are a Premium featureUpgrade →

DateIndicatorDetails

Jul 11▲ MACD Positive CrossoverHistogram +0.1012, positive momentum

Jul 10▲ MACD Positive CrossoverHistogram +0.0655, positive momentum

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Links

More Healthcare stocks

Browse all stocks →

Larimar Therapeutics, Inc.

News & analytics is part of Premium.

Technical readouts are part of Premium.